Preparation method of intestinal targeting type high-absorption ganoderma lucidum composite fermented drink
By using enzymatic compounding and nano-assembly technology, a highly absorbable Ganoderma lucidum compound fermented beverage with intestinal targeting was constructed. This solved the problems of the active ingredients in liquid being easily destroyed and having low absorption efficiency in the gastric acid environment, and realized the stable and bioavailability of Ganoderma lucidum active ingredients for intestinal targeted delivery and efficient absorption.
Patent Information
- Application Number
- CN202610150547.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-02-03
- Publication Date
- 2026-05-05
AI Technical Summary
Existing technologies make it difficult to achieve intestinal-targeted delivery and efficient absorption of Ganoderma lucidum active ingredients in liquid beverages. In particular, hydrophobic triterpenoids are easily destroyed in the acidic environment of the stomach and have low absorption efficiency and unstable bioavailability in the intestine.
Enzymatic compounding was used to glycosylate Ganoderma lucidum polysaccharides and prebiotic oligosaccharides to form a stable polysaccharide-prebiotic complex. The complex was then formed into a pH-responsive coating on a triterpenoid compound through in-situ nanoassembly. Nanoparticles were constructed using electrostatic layer-by-layer self-assembly technology to achieve intestinal-targeted delivery of active ingredients.
The product achieves stability and intestinal targeting of Ganoderma lucidum active ingredients in liquid beverages, significantly improving the absorption and bioavailability of active ingredients. The product maintains stable physicochemical properties during its shelf life and has good commercialization potential.